Nootropic

Methyliberine

Also known as: Dynamine™, methylliberine

Evidence

Methyliberine is a purine alkaloid structurally similar to caffeine that is proposed to enhance energy, focus, and mood through dopaminergic and adenosinergic mechanisms. Clinical evidence in humans is very limited, with most data derived from preliminary in vitro and animal studies.

Primary uses

Mental energy and alertness
Cognitive focus
Mood enhancement
Physical performance support

How it works

Adenosine receptor antagonism (similar to caffeine)
Proposed dopamine pathway modulation
Potential monoamine oxidase inhibition

Dosage

Typical range: 100-300 mg daily
Timing: Morning or early afternoon to avoid sleep disruption
With food: May be taken with or without food
Duration: No established long-term safety data; use as directed on label
Special populations: Not studied in pregnant/nursing women, children, or those with cardiovascular conditions; avoid if sensitive to stimulants

Forms

Capsule· 70/100
Powder· 70/100

Safety

Common side effects

Jitteriness (potential)
Sleep disturbance (if taken late)
Headache (potential)
Increased heart rate (potential)

Contraindications

Pregnancy and lactation (insufficient safety data)
Cardiovascular disease or hypertension
Anxiety disorders
Caffeine sensitivity

Evidence notes

Methyliberine has virtually no published human clinical trials. Available evidence is limited to proprietary research, in vitro studies, and unpublished manufacturer data. Grade D reflects the absence of peer-reviewed RCT evidence in human populations.

Grade D: Primarily pre-clinical or anecdotal; human efficacy not established.

Related in Nootropic

Check a full stack

Formulate's free interaction checker lets you paste in any combination of supplements and medications at once — every pairing flags severity, timing, and cited evidence.

Open the checker

Medical disclaimer. This page is educational and does not replace advice from a qualified healthcare provider.